Listing of Nyrada Inc. spin-off on ASX
Filed with ASX · · 3 pages · English
In the deck
Story so far
Earlier from Noxopharm
- DARRT-1 Clinical Data Webinar
- Nyrada IPO Offer Fully Subscribed
- Lodgement of Nyrada Inc Supplementary Prospectus
- Nyrada Inc Initial Public Offering Opens
- Positive DARRT-1 Data in Late-Stage Prostate Cancer
Later from Noxopharm
- Noxopharm Dec 2019 Appendix 4C
- $8.1M Financing & Re-Set of Capital Structure
- LuPIN Trial Interim Results Indicate Striking Survival Benefit
- Noxopharm Alliance With GenesisCare
- FDA grants IND approval to Veyonda
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm